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Abstract The possible participation of calmodulin in the
activation of store-operated Ca2+ entry (SOC) in single rat
hepatocytes was investigated microspectrofluorimetrically. SOC
was triggered after discharging intracellular Ca2+ stores using
the endoplasmic reticulum Ca2+-ATPase inhibitor thapsigargin
in the absence of external Ca2+. Re-admission of bath Ca2+
caused a rapid and pronounced Ca2+ entry. The calmodulin
antagonists calmidazolium or CGS 9343B applied before the
thapsigargin treatment inhibited SOC, whereas they were
ineffective when added after the thapsigargin-induced Ca2+
transient. This study suggests that activation of calmodulin after
the elevation of cytosolic Ca2+ associated with the emptying of
Ca2+ stores is involved in the triggering of SOC in hepatocytes.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Calcium in£ux from the extracellular milieu is essential to
ensure the cell’s responsiveness to Ca2-mobilizing agonists in
non-excitable cells. The dominant Ca2 entry mechanism in
non-excitable cells such as hepatocytes is mediated by the so-
called store-operated Ca2 entry (SOC), also dubbed capaci-
tative Ca2 entry (for recent reviews see [1,2]). This Ca2
entry process is governed by the Ca2 content of the ago-
nist-sensitive intracellular Ca2 stores, which, when depleted
either by an agonist or by other means, activate a Ca2 con-
ductance at the plasma membrane. The membrane channel
responsible for this Ca2 in£ux has been identi¢ed ¢rst in
Drosophila (trp gene [3]) and later in mammalian cells [4^6].
Despite intense work by numerous researchers, the nature of
the mechanism that senses the ¢lling state of the intracellular
Ca2 stores and communicates it to the cell membrane is still
a matter of debate. A number of putative mechanisms have
been proposed and partly demonstrated, but so far none is
accepted as the unifying theory [1,2]. This could indicate that
the linkage between the intracellular stores and the cell mem-
brane is a complex mechanism, not necessarily common to all
types of non-excitable cells.
In a physiological situation, the depletion of intracellular
Ca2 stores that is brought about by agonist stimulation in
hepatocytes is accompanied by a sustained, transient or pul-
satile elevation of the cytosolic Ca2 concentration [7] depend-
ing on the type and concentration of the agonist. Many cel-
lular responses that are controlled by Ca2-dependent
pathways utilize calmodulin (CAM) as mediator of signaling
[8,9]. CAM has been shown to activate multiple cellular proc-
esses either through direct interaction with target proteins or
via activation of regulatory proteins such as kinases or phos-
phatases [10]. In the present study, we present evidence for the
involvement of CAM in the activation of SOC in rat hepato-
cytes. The pathway used by CAM to activate SOC might
include the CAM-dependent protein kinase II.
2. Materials and methods
Rat hepatocytes were isolated from male Wistar rats and attached
to collagen-coated glass coverslips as described previously [11]. Intra-
cellular Ca2 was measured after loading of the cells with 4^6 WM
fura-2 acetoxymethyl ester for 20 min at 37‡C in Ham’s F12 medium
with 1% bovine serum albumin (BSA) and an additional incubation in
a dye-free medium for another 10 min. Cells were then mounted on
the stage of an inverted £uorescence microscope (Nikon, Tokyo, Ja-
pan) equipped with a 100U1.3 NA objective lens (Nikon) and a ¢lter
wheel (Lambda 10, Sutter Instrument, Novato, CA, USA) for rapid
switching of excitation light between 340 nm and 380 nm. Emission
£uorescence was re£ected by a 400 nm dichroic mirror and ¢ltered
through a 520 nm long-pass ¢lter. Fluorescent images were captured
by a video camera with image intensi¢er (Videoscope Int., Washing-
ton, DC, USA) and digitized by an 8 bit image processor (Leutron,
Glattburg, Switzerland) for quantitative analysis of intensity in se-
lected regions of interest in single cells. Cells were superfused at
33‡C in a thermostatted perfusion chamber. Calibration of cytosolic
Ca2 signal was accomplished in situ at the end of each experiment as
previously described [12,13].
Bath solution contained (mM): 145 NaCl, 5.6 KCl, 0.8 MgSO4, 1.8
CaCl2, 10 HEPES, 10 glucose. A corresponding Ca2-free solution
contained 0.1 mM EGTA without added Ca2. Fura-2 acetoxymethyl
ester was from Molecular Probes (Eugene, OR, USA). Ham’s F12
medium, BSA, thapsigargin, ionomycin, W-7, calmidazolium (i.e.
Compound R24571) and KN-62 were from Sigma (St. Louis, MO,
USA). J-8 was from Alexis Corp. (Laºufel¢ngen, Switzerland). CGS
9343B was kindly provided by Ciba Geigy (Basel, Switzerland). The
other chemicals were from Fluka (Buchs, Switzerland).
Data are presented as means þ S.E.M. from separate preparations.
When appropriate, unpaired Student’s t-test was performed to assess
the statistical signi¢cance of di¡erences, and a value of P lower than
0.05 was considered signi¢cant.
3. Results and discussion
In a ¢rst step, the presence of SOC was tested in our iso-
lated rat hepatocyte preparation. Fig. 1A shows that when
Ca2 was removed from the bath and subsequently re-added
without any other manipulation, the cytosolic Ca2 concen-
tration was practically not a¡ected, indicating that the hepa-
tocyte cell membrane possesses a low permeability for Ca2 in
resting conditions. Addition of thapsigargin (1 WM), a classi-
cal inhibitor of the endoplasmic reticulum (ER) Ca2-ATPase,
discharged the intracellular Ca2 stores and produced an as-
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sociated transient Ca2 rise in the cytosolic compartment (Fig.
1B). After this maneuver, re-admission of Ca2 in the bath
caused a rapid and substantial entry of Ca2. As observed in
other studies [1], this procedure revealed in rat hepatocytes the
existence of a Ca2 in£ux component that becomes activated
by depletion of intracellular Ca2 stores. Another inhibitor of
ER Ca2-ATPase, 2,5-di-(tert-butyl)-1,4-benzohydroquinone,
had the same e¡ects (n = 4, data not shown) indicating that
the observed activation of Ca2 entry was not speci¢c to
thapsigargin, but was due to the depletion of the intracellular
Ca2 stores.
In order to test whether CAM was involved in the signaling
between the intracellular stores and the cell membrane entry
channels, the e¡ects of classical CAM antagonists were tested.
Fig. 1C shows an experiment where the CAM inhibitor cal-
midazolium (10 WM) [14] applied before the discharge of
stores prevented Ca2 entry after subsequent re-admission of
Ca2 in the bath.
Activation of CAM normally occurs after an elevation of
Ca2 which binds to and activates CAM. In order to inves-
tigate whether the thapsigargin-induced cytosolic Ca2 tran-
sient was necessary for the CAM inhibitor to show its e¡ects,
the experimental protocol was modi¢ed such that the calmid-
azolium was added after the Ca2 transient, when cytosolic
Ca2 was back to baseline (Fig. 1D). In this situation, cal-
midazolium did not produce inhibition and re-admission of
Ca2 to the bath resulted in the same rapid and large Ca2
in£ux as in the control condition (Fig. 1B). The signi¢cance of
this result is discussed below.
A series of CAM antagonists were tested for their ability to
inhibit SOC using the protocol described in Fig. 1C,D. Be-
sides calmidazolium, the inhibitors tested were CGS 9343B
[15], W-7, and J-8 [16]. In addition, the substance KN-62, a
speci¢c inhibitor of the CAM-dependent protein kinase II
[17], was tested using the same experimental protocol. The
antagonists were applied at a dose usually used in other stud-
ies (e.g. [18^20]). J-8 was used at a concentration close to its
IC50 of 3 WM [16].
The amplitude of the Ca2 rise (in nM) after re-admission
of Ca2 to the bath was used as a measurement of SOC. In
the control group, Ca2 entry increased cytosolic Ca2 con-
centration by 1070 þ 76 nM. Fig. 2A shows that application of
all CAM antagonists of this series before the thapsigargin-
induced Ca2 discharge reduced the subsequent Ca2 entry
by more than 75%, con¢rming the results presented in Fig.
1C with calmidazolium.
It has been shown by several groups that some CAM an-
tagonists as well as KN-62 could directly block voltage-gated
calcium channels (e.g. [21,22]). To our knowledge such an
interaction has not been demonstrated with SOC channels
of hepatocytes. However, because the results of Fig. 2A do
not allow us to discriminate between a CAM-mediated e¡ect
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Fig. 1. Inhibition of store-operated Ca2 entry by the CAM antagonist calmidazolium. The e¡ects of switching from a Ca2-containing bath
medium to a Ca2-fee solution and back on cytosolic Ca2 was tested in a control condition (A), and in a situation where the intracellular
stores had been depleted (B) by 1 WM thapsigargin (TG). Addition of the CAM antagonist calmidazolium (CDZ, 10 WM) before the thapsigar-
gin-induced Ca2 transient e¡ectively inhibited Ca2 entry after re-addition of Ca2 to the bath (C), whereas its application after the thapsigar-
gin-induced Ca2 transient was ine¡ective (D). The application of the drugs (arrowheads) and the manipulation of bath Ca2 concentration
(mM) in the experiments are given inside the graphs. The traces represent typical results obtained from the experiments summarized in Fig. 2.
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and a direct blockade of Ca2 entry channels, the CAM an-
tagonists were tested using the protocol described in Fig. 1D,
in which the addition of the antagonist was done after the
thapsigargin-induced Ca2 transient. A time delay of 5
min þ 8 s was respected between the addition of drugs and
re-admission of Ca2 in the bath. Fig. 2B shows that besides
calmidazolium, CGS 9343B and KN-62 did not produce an
inhibition of Ca2 entry when applied after the transient. This
result allows us to rule out a direct interaction of these three
substances with the channel, which would occur regardless of
when the drug is added. To exclude the possibility that the
lack of inhibition exhibited by these substances under these
conditions was due to a shorter exposure time than in the case
of an application prior to the thapsigargin treatment, a 15-
min delay between the addition of calmidazolium and the
Ca2 re-addition was tested and did not inhibit Ca2 entry
either (n = 2).
In contrast, W-7 and J-8, two closely related substances
[16], inhibited Ca2 entry both when applied before and after
the thapsigargin-induced Ca2 transient, suggesting the possi-
bility of a direct blocking action of these substances on the
Ca2 entry channel in addition to their described e¡ects on
CAM. The di¡erential e¡ects of this series of compounds is
consistent with the respective potency and selectivity of the
drugs, which was reported to be signi¢cantly higher for cal-
midazolium and CGS 9343B than for W-7 [23].
KN-62, a speci¢c inhibitor of CAM-dependent protein kin-
ase II [17], is often used by others to identify the mechanism
activated by CAM (e.g. [18]). The inhibition observed when
KN-62 was applied before the thapsigargin-induced cytosolic
Ca2 transient, but not when applied after the transient, tends
to support the conclusion that the CAM kinase II takes part
in the signaling pathway, possibly by phosphorylating the
SOC channel or an associated regulatory protein. This hy-
pothesis is supported by the ¢nding that depletion of cellular
ATP prevents activation of SOC in hepatocytes and in other
cell types [24,25].
The results presented in this study are consistent with a
mechanism in which activation of CAM is a key step in the
activation of SOC in rat hepatocytes and occurs during the
thapsigargin-induced discharge of the intracellular Ca2
stores. CAM in turn activates its target protein ^ possibly
CAM kinase II ^ which places the SOC channel in an active
state. Once in this active state, the Ca2 entry channel is no
longer sensitive to CAM antagonists or to CAM kinase II
inhibitors. Sensitivity of SOC to CAM antagonism has been
found other cell types. A correlation between the amplitude of
the cytosolic Ca2 transient evoked by thapsigargin and the
extent of Ca2 entry, and a sensitivity to W-7 have been
established in ¢broblasts [26]. In thyroid cells [19] KN-62,
calmidazolium, and W-7 attenuated Ca2 entry, although
the CAM-independent mechanism of inhibition (i.e. direct
blockade of Ca2 entry channels) was considered dominant
by the authors.
All CAM antagonists used in the present work, as well as
KN-62, at the doses used in this study had an inhibitory e¡ect
on phenylephrine-induced Ca2 oscillations either by reducing
their frequency or by suppressing them completely (data not
shown). In another study [20], the CAM antagonists CGS
9343B and calmidazolium were both found to reversibly in-
hibit Ca2 oscillations in rat hepatocytes. The authors hy-
pothesized that CAM interacted directly with the myo-inositol
1,4,5-trisphosphate receptor of the intracellular stores to pro-
vide the release process with cytosolic Ca2 sensitivity and
that CAM antagonism resulted in an inhibition of Ca2 mo-
bilization. In view of our present results, the inhibition of
oscillations could be entirely explained by an inhibition of
Ca2 entry, a process that is known to be required for sus-
tained oscillatory response [20].
Taken together, the results of this study with rat hepato-
cytes suggest that CAM becomes activated during the eleva-
tion of cytosolic Ca2 that follows the discharge of intracel-
lular stores and participates in the activation of SOC. The fact
that inhibition of CAM after the Ca2 transient has occurred
did not prevent SOC speaks in favor of a mechanism in
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Fig. 2. E¡ect of various CAM antagonists on store-operated Ca2
entry. The e¡ect of selected CAM antagonists on store-operated
Ca2 entry is presented for a situation where the inhibitor was ap-
plied before (A) and after (B) the thapsigargin-induced Ca2 transi-
ent. Calmidazolium (CDZ), CGS 9343B (CGS), W-7 and J-8 are
compared at concentrations indicated in the graph. The amplitude
of cytosolic Ca2 concentration change in percent after re-addition
of Ca2 was compared to control condition, 100% corresponding to
1070 þ 76 nM Ca2. The number of experiments for each group is
given in the graph. *P6 0.0001; ns, statistically not signi¢cant.
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which, once activated by a CAM-dependent mechanism, SOC
remains so for a certain time.
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